Results 221 to 230 of about 70,258 (243)
Some of the next articles are maybe not open access.
Archives of Surgery, 1985
To the Editor.—We would like to thank Dr Thompson for his comments on our recent article.1We agree that our follow-up was short; however, a recent update of our results indicates a cumulative stroke-free survival of 97% at three years, with 65 patients having been followed up prospectively for this time period.
M P, Colgan, V, Kingston, G, Shanik
openaire +2 more sources
To the Editor.—We would like to thank Dr Thompson for his comments on our recent article.1We agree that our follow-up was short; however, a recent update of our results indicates a cumulative stroke-free survival of 97% at three years, with 65 patients having been followed up prospectively for this time period.
M P, Colgan, V, Kingston, G, Shanik
openaire +2 more sources
Surgical Clinics of North America, 1998
The multitude of actions and interacting components involved in inciting and sustaining myointimal hyperplasia and restenosis effectively precludes the use of a single type of intervention. No pharmacologic approach has been conclusively shown to prevent coronary restenosis after balloon angioplasty or graft restenosis after peripheral arterial bypass.
S A, Kagan, S I, Myers
openaire +2 more sources
The multitude of actions and interacting components involved in inciting and sustaining myointimal hyperplasia and restenosis effectively precludes the use of a single type of intervention. No pharmacologic approach has been conclusively shown to prevent coronary restenosis after balloon angioplasty or graft restenosis after peripheral arterial bypass.
S A, Kagan, S I, Myers
openaire +2 more sources
Hyperhomocysteinemia and Restenosis
European Journal of Cardiovascular Prevention & Rehabilitation, 2001This study was undertaken to assess the effect of plasma homocysteine level on angiographic restenosis 6 months after coronary angioplasty.The plasma homocysteine level was measured in 100 consecutive patients at the time of coronary angioplasty, 56 patients who attended a 6-month follow-up angiogram being enrolled to the study; the 44 patients without
S D, Kumbasar +9 more
openaire +2 more sources
New England Journal of Medicine, 2002
Over the past two decades, percutaneous coronary intervention has revolutionized the treatment of symptomatic coronary artery disease, sparing countless patients the need for surgical revascularization. This year, up to a million procedures are likely to be performed in North America alone. The success of percutaneous coronary intervention has been due
openaire +2 more sources
Over the past two decades, percutaneous coronary intervention has revolutionized the treatment of symptomatic coronary artery disease, sparing countless patients the need for surgical revascularization. This year, up to a million procedures are likely to be performed in North America alone. The success of percutaneous coronary intervention has been due
openaire +2 more sources
Restenosis: Intracoronary brachytherapy
Current Treatment Options in Cardiovascular Medicine, 2002Though interventional strategies have revolutionized the management of patients with symptomatic coronary artery disease, in-stent restenosis has emerged as the single most important limitation of long-term success following percutaneous coronary intervention.
Douglas E., Drachman, Daniel I., Simon
openaire +2 more sources
Restenosis following coronary angioplasty
The International Journal of Cardiac Imaging, 1990The assessment of restenosis following angioplasty has become increasingly important in determining the clinical value of the procedure. Despite this there has been no uniformly accepted methodology for assessing the procedure and consequently the published results have often been misleading with little concensus.
K J, Beatt, P W, Serruys
openaire +2 more sources
The Journal of Cardiovascular Surgery
Endovascular arterial recanalization has become the mainstay therapy for peripheral arterial occlusive disease. Although immediate technical success is achieved in greater than 90% of cases, longer-term results continue to vary based on the clinical presentation, and the treated target lesion.
El Khoury, Rym +5 more
openaire +3 more sources
Endovascular arterial recanalization has become the mainstay therapy for peripheral arterial occlusive disease. Although immediate technical success is achieved in greater than 90% of cases, longer-term results continue to vary based on the clinical presentation, and the treated target lesion.
El Khoury, Rym +5 more
openaire +3 more sources